Document Detail


Clinical benefit of transdermal glyceryl trinitrate when used with an eight hour patch-free period.
MedLine Citation:
PMID:  2126727     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The 24-hour application of transdermal nitrate patches has been associated with rapid development of therapeutic tolerance. Recent reports suggest maintenance of clinical benefit by introducing a daily patch-free period. This study investigates, by means of serial treadmill testing, the efficacy of a new transdermal delivery system when used with an eight hour patch-free period in 16 subjects with chronic stable angina. Concomitant antianginal therapy was permitted. After demonstration of exercise test reproducibility and nitrate responsiveness, subjects entered a double-blind randomised placebo-controlled crossover trial comprising one week of active nitroglycerin patches (10mg/24hrs) and one week of an identical placebo patch. Exercise tests were conducted four hours after patch application on the last day of each of the treatment arms. Daily angina frequency and nitroglycerin consumption were also monitored. There was significant improvement in total exercise duration (16.5%), time to onset of angina (26%), time to 1mm ST depression (22%), and peak heart rate blood pressure product with active patch application. Angina frequency was reduced during the week of active therapy. These results demonstrate the additional efficacy of intermittent transdermal nitroglycerin in a group of subjects with continuing angina despite therapy with beta-blockers and calcium antagonists.
Authors:
D W Whalley; K J Hellestrand
Related Documents :
8970407 - Comparison between metoprolol orally osmotic once daily and metoprolol two or three tim...
15618027 - The effect of an angiotensin-converting enzyme inhibitor and a k+(atp) channel opener o...
3933317 - Comparison of buccal nitroglycerin and oral isosorbide dinitrate for nitrate tolerance ...
12489597 - A review of enhanced external counterpulsation clinical trials.
22315317 - The role of foxo and ppar transcription factors in diet-mediated inhibition of pdc acti...
11893607 - Hemodynamic and autonomic correlates of postexercise hypotension in patients with mild ...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Australian and New Zealand journal of medicine     Volume:  20     ISSN:  0004-8291     ISO Abbreviation:  Aust N Z J Med     Publication Date:  1990 Oct 
Date Detail:
Created Date:  1991-03-20     Completed Date:  1991-03-20     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  1264322     Medline TA:  Aust N Z J Med     Country:  AUSTRALIA    
Other Details:
Languages:  eng     Pagination:  677-81     Citation Subset:  IM    
Affiliation:
Department of Cardiology, Royal North Shore Hospital, Sydney, NSW, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Cutaneous
Aged
Angina Pectoris / drug therapy,  physiopathology*
Double-Blind Method
Drug Administration Schedule
Electrocardiography / drug effects
Exercise Test
Humans
Middle Aged
Nitroglycerin / administration & dosage*,  adverse effects,  therapeutic use
Reproducibility of Results
Chemical
Reg. No./Substance:
55-63-0/Nitroglycerin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Selective inhibition of platelet cyclooxygenase with controlled release, low-dose aspirin.
Next Document:  Sarcocystis infection of human muscle.